Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04354675 · ClinicalTrials.gov registry record · NA
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04354675: Completed NA study, sponsored by Case Comprehensive Cancer Center.
NCT04354675 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04354675, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to help better understand the uptake and impact of genetic testing for women diagnosed with breast cancer who do not meet National Comprehensive Cancer Network (NCCN) criteria for genetic testing. By doing so, the research team will gain a better understanding of the clinical implications for offering genetic testing for all patients recently diagnosed with breast cancer versus only offering genetic testing to those meeting NCCN criteria. By offering genetic counseling and genetic testing to all women recently diagnosed with breast cancer, there will be a shortage of genetic counselors. This study will also assess the feasibility of using artificial intelligence to assist in the genetic counseling process.
Primary Outcome
Up-take of testing for those who do not meet NCCN guidelines for genetic testing
Interventions
- GENETIC Automated program (ChatBot)
- GENETIC Genetics counselor
- OTHER BCGCKQ Survey
- OTHER Satisfaction Survey
- DEVICE Genetic testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2023-03-30 |
| Phase | NA |
What the finished NCT04354675 record still lists
NCT04354675 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Automated program (ChatBot) is the first listed.
NCT04354675 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04354675 about?
NCT04354675 is a clinical study titled "Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer". The purpose of this study is to help better understand the uptake and impact of genetic testing for women diagnosed with breast cancer who do not meet National Comprehensive Cancer Network (NCCN) criteria for genetic testing. By doing so, the research team will gain a better understanding of the cli...
What is the current status of trial NCT04354675?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2021-06-29. Estimated completion is 2023-03-30.
What interventions are being tested in trial NCT04354675?
The interventions under investigation include: Automated program (ChatBot) (GENETIC), Genetics counselor (GENETIC), BCGCKQ Survey (OTHER), Satisfaction Survey (OTHER), Genetic testing (DEVICE).
Who is sponsoring clinical trial NCT04354675?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04354675's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI